Latest Insider Transactions at Mbx Biosciences, Inc. (MBX)
This section provides a real-time view of insider transactions for Mbx Biosciences, Inc. (MBX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MBX Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MBX Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Ali Behbahani |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Ali Behbahani |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Forest Baskett |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Forest Baskett |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Edward T Mathers |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Edward T Mathers |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Mohamad Makhzoumi |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Mohamad Makhzoumi |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Anthony A. Florence Jr. |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Anthony A. Florence Jr. |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Carmen Chang |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Carmen Chang |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Scott D Sandell |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Scott D Sandell |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Rick Yang |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Rick Yang |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Paul Edward Walker |
BUY
Open market or private purchase
|
Indirect |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Paul Edward Walker |
BUY
Conversion of derivative security
|
Indirect |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
James M Cornelius |
BUY
Conversion of derivative security
|
Direct |
102,082
+50.0%
|
-
|
|
Sep 16
2024
|
Frazier Life Sciences X, L.P. |
BUY
Open market or private purchase
|
Direct |
625,000
+12.07%
|
$10,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Frazier Life Sciences X, L.P. |
BUY
Conversion of derivative security
|
Direct |
3,927,774
+50.0%
|
-
|
|
Sep 16
2024
|
New Enterprise Associates 17, L.P. |
BUY
Open market or private purchase
|
Direct |
500,000
+12.15%
|
$8,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
New Enterprise Associates 17, L.P. |
BUY
Conversion of derivative security
|
Direct |
3,114,486
+45.09%
|
-
|
|
Sep 16
2024
|
Orbimed Advisors LLC |
BUY
Open market or private purchase
|
Indirect |
750,000
+20.66%
|
$12,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Orbimed Advisors LLC |
BUY
Conversion of derivative security
|
Indirect |
3,062,215
+50.0%
|
-
|
|
Sep 16
2024
|
Carl L Gordon |
BUY
Open market or private purchase
|
Indirect |
750,000
+20.66%
|
$12,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Carl L Gordon |
BUY
Conversion of derivative security
|
Indirect |
3,062,215
+50.0%
|
-
|
|
Sep 16
2024
|
Tiba Aynechi |
BUY
Open market or private purchase
|
Indirect |
750,000
+25.98%
|
$12,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Tiba Aynechi |
BUY
Conversion of derivative security
|
Indirect |
1,386,335
+50.0%
|
-
|
|
Sep 16
2024
|
P. Kent Hawryluk President & CEO |
BUY
Conversion of derivative security
|
Indirect |
115,914
+22.54%
|
-
|
|
Sep 16
2024
|
P. Kent Hawryluk President & CEO |
BUY
Conversion of derivative security
|
Direct |
283,846
+37.09%
|
-
|
|
Sep 16
2024
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
625,000
+12.07%
|
$10,000,000
$16.0 P/Share
|
|
Sep 16
2024
|
Patrick J Heron |
BUY
Conversion of derivative security
|
Indirect |
3,927,774
+50.0%
|
-
|
|
Sep 16
2024
|
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
1,790,122
+34.2%
|
-
|